8-K
XBRL
CURRENT REPORT
- Company
- MoonLake Immunotherapeutics
- Filed
- February 23, 2026
- Period of Report
- February 18, 2026
- Accession Number
- 0001213900-26-018967
An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →